Kim J S, Steck P A, Gallick G E, Lee J S, Blick M, Hong W K, Lotan R
Department of Tumor Biology, University of Texas MD Anderson Cancer Center, Houston 77030.
J Natl Cancer Inst Monogr. 1992(13):101-10.
The epidermal growth factor receptor (EGF-R) gene is overexpressed or amplified in various human squamous cell carcinomas, including those of the head and neck (HNSCC). Earlier we found that beta-all-trans-retinoic acid (RA) inhibited the growth and suppressed the aberrant squamous cell differentiation of several cultured HNSCC cell lines. Here we examined the effects of RA on the expression and function of EGF-R in two HNSCC cell lines, 1483 and 183, which exhibit distinct states of squamous cell differentiation, EGF-R mRNA levels, and responses to the growth inhibitory effects of RA. Treatment with RA (1 microM, 7 days) of the RA-sensitive 1483 cells decreased the level of EGF-R mRNA two- to four-fold and the binding of 125I-EGF to the cell surface by 30%-35%. In contrast, RA treatment of the 183 cells did not alter the EGF-R mRNA level or the binding of 125I-EGF. Other effects of RA on EGF-R structure and function were similar in both cell lines. RA did not alter the amount of immunoprecipitable [35S]methionine-labeled cellular EGF-R, 125I-cell surface labeled EGF-R, EGF-R internalization, or transforming growth factor alpha (TGF-alpha) mRNA. More important, RA treatment of both cell lines decreased EGF-R autophosphorylation activity detected in immune-complex-kinase assay by about three- and five-fold in the 1483 and 183 cells, respectively. Likewise, RA decreased the glycosylation of EGF-R in both cell lines. In the 1483 cells, RA suppressed the incorporation of either glucosamine or fucose by about 50%, whereas in the 183 cells RA suppressed the incorporation of fucose by about 80%. These results demonstrate that RA can modify the structure of the EGF-R by decreasing its glycosylation and suggest that these changes may suppress the autophosphorylation activity of the receptor kinase. The RA-induced changes in EGF-R do not correlate with the effect of RA on the growth of the cells but may be related to the suppression of squamous cell differentiation in the 1483 cells.
表皮生长因子受体(EGF-R)基因在包括头颈部鳞状细胞癌(HNSCC)在内的多种人类鳞状细胞癌中过度表达或扩增。我们之前发现,全反式维甲酸(RA)可抑制几种培养的HNSCC细胞系的生长并抑制异常的鳞状细胞分化。在此,我们研究了RA对两种HNSCC细胞系1483和183中EGF-R表达和功能的影响,这两种细胞系表现出不同的鳞状细胞分化状态、EGF-R mRNA水平以及对RA生长抑制作用的反应。用RA(1 microM,7天)处理对RA敏感的1483细胞,使EGF-R mRNA水平降低了2至4倍,125I-EGF与细胞表面的结合减少了30%-35%。相比之下,用RA处理183细胞并未改变EGF-R mRNA水平或125I-EGF的结合。RA对两种细胞系中EGF-R结构和功能的其他影响相似。RA未改变免疫沉淀的[35S]甲硫氨酸标记的细胞EGF-R量、125I-细胞表面标记的EGF-R、EGF-R内化或转化生长因子α(TGF-α)mRNA。更重要的是,用RA处理两种细胞系后,在免疫复合物激酶测定中检测到的EGF-R自磷酸化活性在1483和183细胞中分别降低了约3倍和5倍。同样,RA降低了两种细胞系中EGF-R的糖基化。在1483细胞中,RA使氨基葡萄糖或岩藻糖的掺入量分别抑制了约50%,而在183细胞中,RA使岩藻糖的掺入量抑制了约80%。这些结果表明,RA可通过降低EGF-R的糖基化来改变其结构,并提示这些变化可能抑制受体激酶的自磷酸化活性。RA诱导的EGF-R变化与RA对细胞生长的影响无关,但可能与1483细胞中鳞状细胞分化的抑制有关。